Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 

Learn More

VICC toll-free number 1-877-936-8422

Clinical Trial VICCGI0721

Title

Vanderbilt Hereditary Colorectal Cancer Registry

Principal Investigator(s)

Timothy Geiger

Details

  • Protocol No. VICCGI0721
  • Open Date: 01/09/2007
  • Staging: N/A
  • Age Group: Adults
  • Scope: Local
  • Objective: To identify patients and their family members who either have a hereditary colorectal cancer or polyposis syndrome or are at high risk for developing hereditary colorectal cancer.
  • Disease Sites: Gastrointestinal; Colon; Rectal
  • Therapies: None Specified
  • Drugs: None Specified
  • Participating Institutions: Vanderbilt University
  • National Clinical Trial ID: NCT00675636
  • Secondary Protocol No: Not Specified

Description

None Provided.

Eligibility

Ages Eligible for Study:N/A and older
Genders Eligible for Study:Both
Accepts Healthy Volunteers:No

Criteria

DISEASE CHARACTERISTICS:
• Meets any of the following criteria:
• Patients and family members with a known hereditary colorectal cancer or polyposis syndrome
• Patients who meet Amsterdam I, II, or Bethesda criteria
• Patients with a family history suggestive of a hereditary colorectal or polyposis syndrome
• Patients diagnosed with colorectal cancer at < 50 years old
• Patients are identified through surgical, oncological, gynecological, and gastrointestinal programs, as well as outside referrals, self referral, and the Vanderbilit Tumor Registry
PATIENT CHARACTERISTICS:
• See Disease Characteristics
PRIOR CONCURRENT THERAPY:
• Not specified